Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4318
Gene Symbol: MMP9
MMP9
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.400 AlteredExpression LHGDN Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9. 18167127

2008

Entrez Id: 4318
Gene Symbol: MMP9
MMP9
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.400 AlteredExpression LHGDN Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression. 19010864

2008

Entrez Id: 4318
Gene Symbol: MMP9
MMP9
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.400 AlteredExpression LHGDN CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer. 18852494

2008

Entrez Id: 4318
Gene Symbol: MMP9
MMP9
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.400 Biomarker LHGDN The ratio of matrix metalloproteinase to E-cadherin expression: a pilot study to assess mRNA and protein expression among African American prostate cancer patients. 18618693

2008

Entrez Id: 4318
Gene Symbol: MMP9
MMP9
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.400 GeneticVariation LHGDN TSP1 and MMP9 genetic variants in sporadic prostate cancer. 17175378

2007

Entrez Id: 4318
Gene Symbol: MMP9
MMP9
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.400 AlteredExpression LHGDN CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. 16114056

2006

Entrez Id: 4318
Gene Symbol: MMP9
MMP9
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.400 AlteredExpression LHGDN Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer. 15356679

2004

Entrez Id: 4318
Gene Symbol: MMP9
MMP9
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.400 Biomarker LHGDN Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement. 12372334

2002